Lu Caibao, Wang Yiqin, Wang Daihong, Nie Ling, Zhang Ying, Lei Qiuyu, Xiong Jiachuan, Zhao Jinghong
Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Kidney Center of PLA, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Kidney Dis (Basel). 2020 Mar;6(2):109-118. doi: 10.1159/000504601. Epub 2019 Dec 11.
The relationship between magnesium and mortality in hemodialysis patients has been evaluated in several prospective studies, but few have assessed the risk of all-cause mortality in elderly hemodialysis patients. The aim of this study was to evaluate the association between magnesium levels and the risk of cardiovascular and overall mortality in elderly maintenance hemodialysis patients.
This was a retrospective study, and patients undergoing maintenance hemodialysis were screened for eligibility at a single dialysis center between July and December 2016. Patients were divided into two groups based on their magnesium levels: a low magnesium level group and a high magnesium level group. Associations between magnesium level and risk of cardiovascular and all-cause mortality were analyzed with a Cox proportional hazards regression model.
In total, 413 patients were included with a median follow-up period of 12 months. We found that compared to patients with high magnesium levels, those with low magnesium levels had significantly lower levels of hemoglobin, urea, creatinine, uric acid, phosphate, potassium, chloride, albumin, and spKt/V ( < 0.05 for each parameter). There was a strong correlation between the baseline mean serum magnesium concentration 1 year prior and the concentration 1 year later ( = 0.519, < 0.001). After adjustment for confounding factors, multivariate Cox proportional hazards analysis showed hypomagnesemia to be an independent predictor of all-cause and cardiovascular mortality in chronic hemodialysis patients. Furthermore, subgroup analysis was performed, revealing that serum magnesium levels were still strongly associated with all-cause mortality and cardiovascular mortality in patients older than 60 years, with HR values of 0.020 (95% CI 0.001-0.415) and 0.010 (95% CI 0.000-0.491), respectively. In addition, there were still significant associations between the serum magnesium level and all-cause mortality and cardiovascular mortality in elderly dialysis patients at the 6-month follow-up visit.
Our study indicates that lower serum magnesium levels are strongly associated with cardiovascular and all-cause mortality in maintenance hemodialysis patients, especially in the short term and in those who are elderly. Factors affecting serum magnesium concentrations in hemodialysis patients should be investigated, and correcting hypomagnesemia may benefit elderly hemodialysis patients.
多项前瞻性研究评估了血液透析患者中镁与死亡率之间的关系,但很少有研究评估老年血液透析患者的全因死亡风险。本研究的目的是评估老年维持性血液透析患者镁水平与心血管及全因死亡风险之间的关联。
这是一项回顾性研究,于2016年7月至12月在单个透析中心对接受维持性血液透析的患者进行资格筛选。根据患者的镁水平将其分为两组:低镁水平组和高镁水平组。采用Cox比例风险回归模型分析镁水平与心血管及全因死亡风险之间的关联。
共纳入413例患者,中位随访期为12个月。我们发现,与高镁水平患者相比,低镁水平患者的血红蛋白、尿素、肌酐、尿酸、磷酸盐、钾、氯、白蛋白和spKt/V水平显著更低(各参数P<0.05)。1年前的基线平均血清镁浓度与1年后的浓度之间存在强相关性(r=0.519,P<0.001)。在对混杂因素进行调整后,多变量Cox比例风险分析显示低镁血症是慢性血液透析患者全因和心血管死亡的独立预测因素。此外,进行了亚组分析,结果显示血清镁水平在60岁以上患者中仍与全因死亡和心血管死亡密切相关,HR值分别为0.020(95%CI 0.001-0.415)和0.010(95%CI 0.000-0.491)。此外,在6个月随访时,老年透析患者的血清镁水平与全因死亡和心血管死亡之间仍存在显著关联。
我们的研究表明,较低的血清镁水平与维持性血液透析患者的心血管及全因死亡密切相关,尤其是在短期内以及老年患者中。应研究影响血液透析患者血清镁浓度的因素,纠正低镁血症可能使老年血液透析患者受益。